Illumina’s rejection of Roche’s offer
Illumina Inc., a company specialized in developing life sciences tools and systems for genetic analysis, has rejected the Roche’s offer
Read moreRoche
Roche has expanded the tender offer for Illumina
Roche, a Switzerland based company specialized in pharmaceuticals and diagnostics, has announced that the tender offer for Illumina has been
Read moreZelboraf, skin cancer medicine, has gotten approval from European Drug Regulators
Roche has announced, on Monday, that the European Drug Regulators have approved the company’s new skin cancer medicine, i.e. Zelboraf
Read moreAvastin did not fulfill expectations about ovarian cancer treatment
Avastin, an anticancer drug by Genentech which got approval in Europe last week for advanced ovarian cancer, has lost expectations
Read moreTwo new auspicious therapeutic strategies against Breast Cancer
Two companies have raised a strong hope for the treatment of breast cancer. These companies are Roche and Novartis. Breast
Read more